Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial

Authors:

Abstract
No abstract available

This publication has 37 references indexed in Scilit: